| Efficacy and safety of high-specific-activity 131I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma DA Pryma, BB Chin, RB Noto, JS Dillon, S Perkins, L Solnes, ... Journal of Nuclear Medicine 60 (5), 623-630, 2019 | 267 | 2019 |
| Synergistic co‐targeting of prostate‐specific membrane antigen and androgen receptor in prostate cancer JD Murga, SM Moorji, AQ Han, WW Magargal, VA DiPippo, WC Olson The Prostate 75 (3), 242-254, 2015 | 97 | 2015 |
| PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label … DP Petrylak, NJ Vogelzang, K Chatta, MT Fleming, DC Smith, ... The Prostate 80 (1), 99-108, 2020 | 72 | 2020 |
| Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer DP Petrylak, P Kantoff, NJ Vogelzang, A Mega, MT Fleming, ... The Prostate 79 (6), 604-613, 2019 | 67 | 2019 |
| Differential gene expression technologies for identifying surrogate markers of drug efficacy and toxicity JA Rininger, VA DiPippo, BE Gould-Rothberg Drug Discovery Today 5 (12), 560-568, 2000 | 62 | 2000 |
| Efficacy studies of an antibody‐drug conjugate PSMA‐ADC in patient‐derived prostate cancer xenografts VA DiPippo, WC Olson, HM Nguyen, LG Brown, RL Vessella, E Corey The Prostate 75 (3), 303-313, 2015 | 47 | 2015 |
| Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized-thyroidectomized rat VA DiPippo, R Lindsay, CA Powers Endocrinology 136 (3), 1020-1033, 1995 | 47 | 1995 |
| Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer VA DiPippo, HM Nguyen, LG Brown, WC Olson, RL Vessella, E Corey The Prostate 76 (3), 325-334, 2016 | 34 | 2016 |
| A phase 2 trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC). DP Petrylak, DC Smith, LJ Appleman, MT Fleming, A Hussain, R Dreicer, ... Journal of Clinical Oncology 32 (15_suppl), 5023-5023, 2014 | 26 | 2014 |
| The characterization of PPARα ligand drug action in an in vivo model by comprehensive differential gene expression profiling BE Gould Rothberg, SS Sundseth, VA DiPippo, PJ Brown, DA Winegar, ... Functional & integrative genomics 1, 294-304, 2001 | 25 | 2001 |
| A phase 2 study of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in patients (pts) with progressive metastatic castration-resistant prostate cancer … DP Petrylak, NJ Vogelzang, GS Chatta, MT Fleming, DC Smith, ... Journal of Clinical Oncology 33 (7_suppl), 144-144, 2015 | 23 | 2015 |
| Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat VA Dipippo, CA Powers Journal of Pharmacology and Experimental Therapeutics 281 (1), 142-148, 1997 | 18 | 1997 |
| Estrogen induction of growth hormone in the thyroidectomized rat VA DiPIPPO, CA POWERS Endocrinology 129 (4), 1696-1700, 1991 | 15 | 1991 |
| Biological thiols elicit prolactin proteolysis by glandular kallikrein and permit regulation by biochemical pathways linked to redox control MA Hatala, VA DiPippo, CA Powers Biochemistry 30 (31), 7666-7672, 1991 | 15 | 1991 |
| Proteins and nucleic acids encoding same P Mezes, L Rastelli, J Herrmann, J MacDougall, H Zhong, S Casman, ... US Patent 7,141,549, 2006 | 10 | 2006 |
| Combination therapies with psma ligand conjugates WC Olson, V Dipippo US Patent App. 14/277,367, 2015 | 9 | 2015 |
| Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma C Jimenez, BB Chin, RB Noto, JS Dillon, L Solnes, N Stambler, ... Endocrine-related cancer 30 (2), 2023 | 8 | 2023 |
| Azedra (iobenguane I 131) in patients with malignant, recurrent and/or unresectable pheochromocytoma or paraganglioma (PPGL): Updated efficacy and safety results from a multi … D Pryma, B Chin, R Noto, J Dillon, L Solnes, T White, N Stambler, T Lin, ... Journal of Clinical Oncology 36 (15_suppl), 4005-4005, 2018 | 8 | 2018 |
| Novel proteins and nucleic acids encoding same M Agee, J Alsobrook, C Berghs, F Boldog, C Burgess, J Chant, ... US Patent App. 10/287,226, 2004 | 7 | 2004 |
| Novel proteins and nucleic acids encoding same M Agee, J Alsobrook, D Anderson, C Berghs, F Boldog, C Burgess, ... US Patent App. 10/236,417, 2004 | 7 | 2004 |
